Clinical Trials Logo

Clinical Trial Summary

A single 2% topical application of ReadyPrep® CHG was applied on either the abdomen (Treatment-1) or the groin (Treatment-2) whereas Treatment-3 consisted of a control treatment where the same procedure as Treatment-1 and -2 was performed, but without the topical application of ReadyPrep® CHG. The treatments were separated by a wash-out of 7 calendar days.


Clinical Trial Description

n/a


Study Design


Related Conditions & MeSH terms


NCT number NCT03331263
Study type Interventional
Source Medline Industries
Contact
Status Completed
Phase Phase 1
Start date July 21, 2017
Completion date August 6, 2017

See also
  Status Clinical Trial Phase
Completed NCT03681990 - In Vivo Preoperative Skin Preparation Efficacy Study Within a Defined Product Coverage Area Phase 2
Completed NCT04756154 - Efficacy Study of Patient Preoperative Preps In-vivo Phase 3
Completed NCT02831998 - In-vivo Efficacy of Patient Preoperative Prep Phase 3
Completed NCT03782103 - In-vivo Efficacy of Patient Preoperative Prep, ZuraPrep (ZP) Phase 3
Completed NCT02831816 - Clinical Evaluation of Patient Preoperative Prep Phase 3